SNDX-5613
Product Specifications
CAS Number
2169919-21-3
Target
Histone Methyltransferase, Epigenetic Reader Domain
Related Pathways
Chromatin/Epigenetic
Purity
0.9974
Bioactivity
Revumenib (SNDX-5613) is a potent and selective oral inhibitor of menin-KMT2A interaction with Ki of 0.149 nM and IC50 between 10 and 20 nM, which can be used in the study of acute leukemia with MLL gene rearrangement.
Smiles
CCN(C(C)C)C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(C1)CCN(C[C@H]1CC[C@@H](CC1)NS(=O)(=O)CC)CC2
Molecular Formula
C32H47FN6O4S
Molecular Weight
630.82
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1793703 1.0 µg DNA
RBM15 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
RA0692-01 100 µg
Upinitatug (Biosimilar Reference Antibody) (SLC34A2)
Sign In for Pricing
View Details RA0692-02 1 mg
Upinitatug (Biosimilar Reference Antibody) (SLC34A2)
Sign In for Pricing
View Details RA0692-03 5 mg
Upinitatug (Biosimilar Reference Antibody) (SLC34A2)
Sign In for Pricing
View Details RA0692-04 10 mg
Upinitatug (Biosimilar Reference Antibody) (SLC34A2)
Sign In for Pricing
View Details